Angiotensin Antagonism in Coronary Artery Disease: Results after Coronary Revascularisation

By Ribichini Flavio   Ferrero Valeria   Rognoni Andrea   Vacca Giovanni   Vassanelli Corrado  

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1073-1096

Adis International

Access to resources Recommend Favorite

Pharmacological Treatment of Patients with Peripheral Arterial Disease

By Kim C.K.   Schmalfuss C.M.   Schofield R.S.   Sheps D.S.  

Drugs, Vol. 63, Iss. 7, 2003-01 ,pp. : 637-647

Adis International

Access to resources Recommend Favorite

Abciximab: An Updated Review of its Therapeutic Use in Patients with Ischaemic Heart Disease Undergoing Percutaneous Coronary Revascularisation

By Ibbotson T.   McGavin J.K.   Goa K.L.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1121-1163

Adis International

Access to resources Recommend Favorite

Gene therapy for coronary and peripheral artery disease

By Nikol Sigrid  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 8, 2008-08 ,pp. : 903-927

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 225-228

Informa Healthcare

Access to resources Recommend Favorite